Literature DB >> 3297122

The pressor dose-response in clinical cardiovascular pharmacology.

D J Sumner, H L Elliott.   

Abstract

Mesh：

Year:  1987        PMID： 3297122      PMCID： PMC1386184          DOI： 10.1111/j.1365-2125.1987.tb03084.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man.

Authors:  D J Sumner; H L Elliott; J Vincent; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

2.  Cardiovascular responses to infused epinephrine: effect of the state of physical conditioning.

Authors:  S J Mann; L R Krakoff; K Felton; K Yeager
Journal:  J Cardiovasc Pharmacol       Date:  1984 Mar-Apr       Impact factor: 3.105

3.  Circadian rhythms in rat brain alpha- and beta-adrenergic receptors are modified by chronic imipramine.

Authors:  A Wirz-Justice; M S Kafka; D Naber; T A Wehr
Journal:  Life Sci       Date:  1980-07-28       Impact factor: 5.037

4.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

5.  Analysis of phenylephrine in plasma: initial data about the concentration-effect relationship.

Authors:  A Martinsson; S Bevegård; P Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Metabolic and cardiovascular responses to norepinephrine in trained and nontrained human subjects.

Authors:  J LeBlanc; M Boulay; S Dulac; M Jobin; A Labrie; S Rousseau-Migneron
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-02

7.  Trimazosin: relationships between hypotensive effect, vascular responsiveness, and drug and metabolite concentrations.

Authors:  J Vincent; H L Elliott; P A Meredith; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1985 Sep-Oct       Impact factor: 3.105

8.  Analysis of the pressor dose response.

Authors:  D J Sumner; H L Elliott; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875
  8 in total
  11 in total

1.  A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.

Authors:  S Ueda; P A Meredith; C A Howie; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

2.  Pharmacological properties of nebivolol in man.

Authors:  L M Van Bortel; J N de Hoon; M J Kool; J A Wijnen; C I Vertommen; L G Van Nueten
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

3.  An evaluation of the alpha-adrenoceptor antagonism produced by SK&F 86466 in healthy normotensive males.

Authors:  R F Schafers; H L Elliott; C A Howie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

4.  A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.

Authors:  G E McVeigh; M McMaster; T Linton; E Whitehead; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.

Authors:  R F Schafers; H L Elliott; C A Howie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

6.  The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.

Authors:  T C Tham; S Guy; B J McDermott; R G Shanks; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

7.  Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.

Authors:  A Martinsson; K Lindvall; A Melcher; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

8.  Lacidipine: effects on vascular pressor responses throughout the dosage interval in normotensive subjects.

Authors:  S Ueda; R Donnelly; V Panfilov; A D Morris; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man.

Authors:  T C Tham; S Guy; R G Shanks; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

10.  Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study.

Authors:  Pash Dhindsa; Karl R Davis; Richard Donnelly
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.